|
[1]
|
Riva, N., Donadini, M.P. and Ageno, W. (2015) Epidemiology and Pathophysiology of Venous Thromboembolism: Similarities with Atherothrombosis and the Role of Inflammation. Thrombosis and Haemostasis, 113, 1176-1183. [Google Scholar] [CrossRef]
|
|
[2]
|
Ay, C., Pabinger, I. and Cohen, A.T. (2017) Cancer-Associated ve-nous Thromboembolism: Burden, Mechanisms, and Management. Thrombosis and Haemostasis, 117, 219-230. [Google Scholar] [CrossRef]
|
|
[3]
|
Riess, H., Habbel, P., Jühling, A., et al. (2016) Primary Prevention and Treatment of Venous Thromboembolic Events in Patients with Gastrointestinal Cancers—Review. World Journal of Gastrointestinal Oncology, 8, 258-270. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Hisada, Y. and Mackman, N. (2017) Cancer-Associated Pathways and Biomarkers of Venous Thrombosis. Blood, 130, 1499-1506. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Mulder, F., Horváth-Puhó, E., Van Es, N., et al. (2021) Ve-nous Thromboembolism in Cancer Patients: A Population-Based Cohort Study. Blood, 137, 1959-1969. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Khalil, J., Bensaid, B., Elkacemi, H., et al. (2015) Venous Throm-boembolism in Cancer Patients: An Underestimated Major Health Problem. World Journal of Surgical Oncology, 13, Ar-ticle No. 204. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Chew, H.K., Wun, T., Harvey, D., et al. (2006) Incidence of Ve-nous Thromboembolism and Its Effect on Survival among Patients with Common Cancers. Archives of Internal Medicine, 166, 458-464. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Mcliesh, P. and Wiechula, R. (2012) Identifying and Reducing the Incidence of Post Discharge Venous Thromboembolism (VTE) in Orthopaedic Patients: A Systematic Review. JBI Li-brary of Systematic Reviews, 10, 1-14. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Karande, G.Y., Hedgire, S.S., Sanchez, Y., et al. (2016) Advanced Imaging in Acute and Chronic Deep Vein Thrombosis. Cardiovascular Diagnosis and Therapy, 6, 493-507. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Heit, J.A. (2015) Epidemiology of Venous Thromboembolism. Na-ture Reviews Cardiology, 12, 464-474. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Stein, P.D., Hull, R.D., Kayali, F., et al. (2004) Venous Thrombo-embolism According to Age: The Impact of an Aging Population. Archives of Internal Medicine, 164, 2260-2265. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Montagnana, M., Favaloro, E.J., Franchini, M., et al. (2010) The Role of Ethnicity, Age and Gender in Venous Thromboembolism. Journal of Thrombosis and Thrombolysis, 29, 489-496. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Dong, H., Liang, X., Gao, Y., et al. (2022) Postoperative Venous Thromboembolism after Surgery for Stage IA Non-Small-Cell Lung Cancer: A Single-Center, Prospective Cohort Study. Thoracic Cancer, 13, 1258-1266. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Douketis, J., Tosetto, A., Marcucci, M., et al. (2011) Risk of Re-currence after Venous Thromboembolism in Men and Women: Patient Level Meta-Analysis. BMJ, 342, d813. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Faiz, A., Guo, S., Sridharan, A., et al. (2023) Venous Thromboembolism and Acute Myeloid Leukemia: Risk Factors and Mortality in Elderly White, Black and Asian Patients. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis, 34, 345-352. [Google Scholar] [CrossRef]
|
|
[16]
|
White, R.H., Zhou, H., Murin, S., et al. (2005) Effect of Ethnicity and Gender on the Incidence of Venous Thromboembolism in a Diverse Population in California in 1996. Thrombosis and Haemostasis, 93, 298-305. [Google Scholar] [CrossRef]
|
|
[17]
|
Matsushita, K. (2016) Pathogenetic Pathways of Cardiorenal Syn-drome and Their Possible Therapeutic Implications. Current Pharmaceutical Design, 22, 4629-4637. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hu, M., Wang, X. and Yang, Y. (2023) Causal Rela-tionship between Moderate to Vigorous Physical Activity and Venous Thromboembolism. Journal of Thrombosis and Thrombolysis, 55, 576-583. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Datta, T., Brunson, A., Mahajan, A., et al. (2022) Racial Dispar-ities in Cancer-Associated Thrombosis. Blood Advances, 6, 3167-3177. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Khan, F., Tritschler, T., Kahn, S.R., et al. (2021) Venous Thromboembolism. The Lancet, 398, 64-77. [Google Scholar] [CrossRef]
|
|
[21]
|
Kearon, C., Ageno, W., Cannegieter, S.C., et al. (2016) Cat-egorization of Patients as Having Provoked or Unprovoked Venous Thromboembolism: Guidance from the SSC of ISTH. Journal of Thrombosis and Haemostasis, 14, 1480-1483. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Timp, J.F., Braekkan, S.K., Versteeg, H.H., et al. (2013) Epidemiology of Cancer-Associated Venous Thrombosis. Blood, 122, 1712-1723. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Van Stralen, K.J., Doggen, C.J., Lumley, T., et al. (2008) The Relationship between Exercise and Risk of Venous Thrombosis in Elderly People. Journal of the American Geriatrics Society, 56, 517-522. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Connolly, G.C. and Khorana, A.A. (2010) Emerging Risk Stratification Approaches to Cancer-Associated Thrombosis: Risk Factors, Biomarkers and a Risk Score. Thrombosis Research, 125, S1-S7. [Google Scholar] [CrossRef]
|
|
[25]
|
Ohashi, Y., Ikeda, M., Kunitoh, H., et al. (2020) Venous Thromboembolism in Cancer Patients: Report of Baseline Data from the Multicentre, Prospective Cancer-VTE Registry. Japanese Journal of Clinical Oncology, 50, 1246-1253. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Wang, J., Hu, B., Li, T., et al. (2019) The EGFR-Rearranged Adenocar-cinoma Is Associated with a High Rate of Venous Thromboembolism. Annals of Translational Medicine, 7, 724. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Mclaughlin, H., Greco, P., Straubhar, A., et al. (2023) Implementa-tion of Routine Venous Thromboembolism Prophylaxis during Neoadjuvant Chemotherapy for Patients with Ovarian Cancer. Gynecologic Oncology, 178, 89-95. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Shafa, A., Watkins, A., Mcgree, M., et al. (2023) Incidence of Venous Thromboembolism in Patients with Advanced Stage Ovarian Cancer Undergoing Neoadjuvant Chemotherapy: Is It Time for Thromboprophylaxis? Gynecologic Oncology, 176, 36-42. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Ren, Y., Chang, L., Zhao, B., et al. (2020) Venous Thromboem-bolism after Peripherally Inserted Central Catheters Placement in Children with Acute Leukemia: A Single-Center Retro-spective Cohort Study. Journal of Pediatric Hematology/Oncology, 42, e407-e409. [Google Scholar] [CrossRef]
|
|
[30]
|
Fuentes, H.E., Tafur, A.J. and Caprini, J.A. (2016) Can-cer-Associated Thrombosis. Disease-a-Month, 62, 121-158. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Marshall-Webb, M., Bright, T., Price, T., et al. (2017) Ve-nous Thromboembolism in Patients with Esophageal or Gastric Cancer Undergoing Neoadjuvant Chemotherapy. Dis-eases of the Esophagus, 30, 1-7. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Basaran, D., Boerner, T., Suhner, J., et al. (2021) Risk of Venous Throm-boembolism in Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy. Gynecologic Oncology, 163, 36-40. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Van Es, N., Hisada, Y., Di Nisio, M., et al. (2018) Extracellular Vesicles Exposing Tissue Factor for the Prediction of Venous Thromboembolism in Patients with Cancer: A Prospective Cohort Study. Thrombosis Research, 166, 54-59. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Mooberry, M.J. and Key, N.S. (2016) Microparticle Analysis in Disorders of Hemostasis and Thrombosis. Cytometry A, 89, 111-122. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Yuana, Y., Bertina, R.M. and Osanto, S. (2011) Pre-Analytical and An-alytical Issues in the Analysis of Blood Microparticles. Thrombosis and Haemostasis, 105, 396-408. [Google Scholar] [CrossRef]
|
|
[36]
|
Cui, C.J., Wang, G.J., Yang, S., et al. (2018) Tissue Factor-Bearing MPs and the Risk of Venous Thrombosis in Cancer Patients: A Meta-Analysis. Scientific Reports, 8, Article No. 1675. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
Grilz, E., Posch, F., Königsbrügge, O., et al. (2018) Association of Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with the Risk of Thromboembolism and Mortality in Patients with Cancer. Thrombosis and Haemostasis, 118, 1875-1884. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Ferroni, P., Riondino, S., Formica, V., et al. (2015) Venous Throm-boembolism Risk Prediction in Ambulatory Cancer Patients: Clinical Significance of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio. International Journal of Cancer, 136, 1234-1240. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Thålin, C., Daleskog, M., Göransson, S.P., et al. (2017) Validation of an Enzyme-Linked Immunosorbent Assay for the Quantification of Citrullinated Histone H3 as a Marker for Neutrophil Ex-tracellular Traps in Human Plasma. Immunologic Research, 65, 706-712. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
Mir Seyed Nazari, P., Marosi, C., Moik, F., et al. (2019) Low Systemic Levels of Chemokine C-C Motif Ligand 3 (CCL3) Are Associated with a High Risk of Venous Thromboem-bolism in Patients with Glioma. Cancers (Basel), 11, Article No. 2020. [Google Scholar] [CrossRef] [PubMed]
|
|
[41]
|
Awkar, N., Amireh, S., Rai, S., et al. (2018) Association between Level of Tumor Markers and Development of VTE in Patients with Pancreatic, Colorectal and Ovarian Ca: Retrospective Case-Control Study in Two Community Hospitals. Pathology and Oncology Research, 24, 283-287. [Google Scholar] [CrossRef] [PubMed]
|
|
[42]
|
Watanabe, J., Natsumeda, M., Okada, M., et al. (2019) Podoplanin Expression and IDH-Wildtype Status Predict Venous Thromboembolism in Patients with High-Grade Glio-mas in the Early Postoperative Period. World Neurosurgery, 128, e982-e988. [Google Scholar] [CrossRef] [PubMed]
|
|
[43]
|
Wang, X., Liu, B., Xu, M., et al. (2021) Blocking Podoplanin In-hibits Platelet Activation and Decreases Cancer-Associated Venous Thrombosis. Thrombosis Research, 200, 72-80. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Anijs, R.J.S., Laghmani, E.H., Ünlü, B., et al. (2022) Tu-mor-Expressed microRNAs Associated with Venous Thromboembolism in Colorectal Cancer. Research and Practice in Thrombosis and Haemostasis, 6, e12749. [Google Scholar] [CrossRef] [PubMed]
|
|
[45]
|
Oto, J., Navarro, S., Larsen, A.C., et al. (2020) MicroRNAs and Neutro-phil Activation Markers Predict Venous Thrombosis in Pancreatic Ductal Adenocarcinoma and Distal Extrahepatic Cholangiocarcinoma. International Journal of Molecular Sciences, 21, Article No. 840. [Google Scholar] [CrossRef] [PubMed]
|
|
[46]
|
Wang, Y., Zhang, Z., Tao, P., et al. (2020) The Abnormal Expression of miR-205-5p, miR-195-5p, and VEGF-A in Human Cervical Cancer Is Related to the Treatment of Venous Thrombo-embolism. BioMed Research International, 2020, Article ID: 3929435. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
Pan, J., Qian, Y., Weiser, P., et al. (2010) Glycosaminoglycans and Activated Contact System in Cancer Patient Plasmas. Progress in Molecular Biology and Translational Science, 93, 473-495. [Google Scholar] [CrossRef]
|
|
[48]
|
Cosmi, B., Legnani, C., Libra, A., et al. (2023) D-Dimers in Diagnosis and Prevention of Venous Thrombosis: Recent Advances and Their Practical Implications. Polish Archives of Internal Medicine, 133, 16604. [Google Scholar] [CrossRef] [PubMed]
|
|
[49]
|
Nickel, K.F., Ronquist, G., Langer, F., et al. (2015) The Polyphos-phate-Factor XII Pathway Drives Coagulation in Prostate Cancer-Associated Thrombosis. Blood, 126, 1379-1389. [Google Scholar] [CrossRef] [PubMed]
|
|
[50]
|
Gerotziafas, G.T., Taher, A., Abdel-Razeq, H., et al. (2017) A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study. Oncologist, 22, 1222-1231. [Google Scholar] [CrossRef] [PubMed]
|
|
[51]
|
Wu, J., Fu, Z., Liu, G., et al. (2017) Clinical Significance of Plasma D-Dimer in Ovarian Cancer: A Meta-Analysis. Medicine (Baltimore), 96, e7062. [Google Scholar] [CrossRef]
|
|
[52]
|
Mauracher, L.M., Posch, F., Martinod, K., et al. (2018) Cit-rullinated Histone H3, a Biomarker of Neutrophil Extracellular Trap Formation, Predicts the Risk of Venous Thrombo-embolism in Cancer Patients. Journal of Thrombosis and Haemostasis, 16, 508-518. [Google Scholar] [CrossRef] [PubMed]
|
|
[53]
|
Posch, F., Thaler, J., Zlabinger, G.J., et al. (2016) Soluble Vascular Endo-thelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS). Clinical Cancer Research, 22, 200-206. [Google Scholar] [CrossRef]
|
|
[54]
|
Reitter, E.M., Kaider, A., Ay, C., et al. (2016) Longitudinal Analysis of Hemostasis Biomarkers in Cancer Patients during Antitumor Treatment. Journal of Thrombosis and Hae-mostasis, 14, 294-305. [Google Scholar] [CrossRef] [PubMed]
|
|
[55]
|
Key, N.S., Khorana, A.A., Kuderer, N.M., et al. (2020) Venous Thromboembolism Prophylaxis and Treatment in Patients with Cancer: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology, 38, 496-520. [Google Scholar] [CrossRef]
|